Advertisement
Advertisement

TIL

TIL logo

Instil Bio, Inc. Common Stock

7.41
USD
Sponsored
+0.13
+1.79%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

7.24

-0.17
-2.28%

Instil Bio, Inc. Common Stock Profile

About

Instil Bio Inc. is a clinical-stage biopharmaceutical company. It is focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer. Instil Bio Inc. is based in DALLAS.

Info & Links

CEO

Bronson Crouch

Headquarters

3963 MAPLE AVENUE, SUITE 350
DALLAS, TX 75219, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

http://instilbio.com

Auditor

Deloitte & Touche LLP

Share holders

13

Employees

17

Instil Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

49.11M

Enterprise Value

129.09M

Enterprise Value/EBITDA(ttm)

-2.35

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.45

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-39.76%

Return on Invested Capital(ttm)

-22.80%

Return on Assets(ttm)

-22.38%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-54.98M

Net Income Available to Common(ttm)

-47.38M

Diluted EPS(ttm)

-7.08

Share Statistics

Beta (5Y Monthly)

1.94

52-Week Change

-71.43%

S&P 500 52-Week Change

21.41%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

6.78M

Dividend Yield

0.00%

Float4

3.59M

% Held by Insiders

47.00%

% Held by Institutions

60.56%

Balance Sheet

Total Cash(mrq)

74.69M

Total Cash Per Share(mrq)

11.01

Total Debt(mrq)

85.00M

Total Debt/Equity(mrq)

76.78%

Current Ratio(mrq)

39.87%

Quick Ratio(mrq)

39.87%

Book Value Per Share(mrq)

16.32

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.20

Free Cash Flow(ytd)

-1.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement